Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis

BACKGROUND: Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors. Recently, AAP have also been shown to exhibit immunomodulatory properties in the central nervous system (CNS). OBJECTIVE:...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mult Scler J Exp Transl Clin
Prif Awduron: Green, Laura K, Zareie, Pirooz, Templeton, Nikki, Keyzers, Robert A, Connor, Bronwen, La Flamme, Anne Camille
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2017
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5453410/
https://ncbi.nlm.nih.gov/pubmed/28607752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317698724
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg